Vertex Pharmaceuticals (VRTX) shares outstanding

Shares outstanding · fiscal 2025
258.00M

Vertex Pharmaceuticals (VRTX) had 258.00M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is level with fiscal 2024. Figures as of 18 Nov 2026, 11:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
258.00M
Change on fiscal 2024
+0.0%
Growth, 5 years
−0.4% a year
Growth, 10 years
+0.7% a year
Highest on record
263.40Mfiscal 2020
Lowest on record
140.56Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Vertex Pharmaceuticals shares outstanding, in more detail

The market data feed counts 253.54M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count shrank at a compound 0.4% a year; over ten years the rate was 0.7% a year. Across the 18 fiscal years on record (2008–2025), the highest was 263.40M in fiscal 2020 and the lowest 140.56M in fiscal 2008.

History · 18 fiscal years

Shares outstanding by fiscal year

Vertex Pharmaceuticals shares outstanding, year by year

Vertex Pharmaceuticals (VRTX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025258.00M 0.0% up
2024257.90M 1.0% down
2023260.50M 0.5% up
2022259.10M 0.3% down
2021259.90M 1.3% down
2020263.40M 1.0% up
2019260.70M 0.6% up
2018259.19M 2.4% up
2017253.23M 3.5% up
2016244.69M 1.4% up
2015241.31M 2.6% up
2014235.31M 4.6% up
2013224.91M 4.5% up
2012215.26M 3.1% up
2011208.81M 4.2% up
2010200.40M 15.7% up
2009173.26M 23.3% up
2008140.56M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Vertex Pharmaceuticals and comparable companies
CompanyShares outstandingFiscal year
Pfizer PFE5.71B2025
Danaher DHR716.10M2025
Intuitive Surgical ISRG362.70M2025
Vertex Pharmaceuticals VRTX258.00M2025
Medtronic MDT1.29B2026
Bristol-Myers Squibb BMY2.04B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on VRTX

Vertex Pharmaceuticals, figure by figure

Vertex Pharmaceuticals (VRTX) overview: price, valuation and scorecardAll health care companies by market value

Vertex Pharmaceuticals shares outstanding: questions and answers

How many shares does Vertex Pharmaceuticals have?

Vertex Pharmaceuticals (VRTX) had 258.00M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is level with fiscal 2024. The market data feed counts 253.54M shares outstanding today.

What is the growth rate of Vertex Pharmaceuticals's diluted share count?

Over the five fiscal years to 2025 the diluted share count shrank at a compound 0.4% a year; over ten years the rate was 0.7% a year.

What are the highest and lowest diluted share count figures on record for Vertex Pharmaceuticals?

Across the 18 fiscal years on record (2008–2025), the highest was 263.40M in fiscal 2020 and the lowest 140.56M in fiscal 2008.

How is Vertex Pharmaceuticals's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Vertex Pharmaceuticals it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vertex Pharmaceuticals (VRTX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/VRTX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.